Announced details
Recruitment of participants for clinical trials and clinical studies, and provision of information to eligible individuals based on disease criteria and prescription and medication status
Trial advertising conducted for 13 projects from 2024
13 projects from 2024 (track record of trial advertising distribution)
The parties have entered into a business alliance agreement. Under the collaboration, EPLink determines the target clinical trial population, and the company distributes advertisements to the relevant users.
Head office: Shinjuku-ku, Tokyo; Representative Director: Nakajima Hirotaka (中島裕尚). Other details: Not disclosed.
In this announcement the company addresses none of Contract Value / Offering price / Impact on Business Performance.
| Item | Details |
|---|---|
| Names of Products / Services Covered | EPARK Medication Handbook, Clinical trial participant recruitment advertising distribution |
| Counterparty | 株式会社EPLink |
| Counterparty overview | Head office: Shinjuku-ku, Tokyo; Representative Director: Nakajima Hirotaka (中島裕尚). Other details: Not disclosed. |
| Relationship with the Company | The parties have entered into a business alliance agreement. Under the collaboration, EPLink determines the target clinical trial population, and the company distributes advertisements to the relevant users. |
| Launch date | 25 August 2026 (advertising distribution launched; actual) |
| Applicable area | Recruitment of participants for clinical trials and clinical studies, and provision of information to eligible individuals based on disease criteria and prescription and medication status |
| Quantitative Effects | Trial advertising conducted for 13 projects from 2024 |
| Usage history | 13 projects from 2024 (track record of trial advertising distribution) |
Items this document does not state (10)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The usefulness of the initiative was confirmed after trial advertising was conducted for 13 projects from 2024 and its operational aspects and effectiveness were verified.